California's Multibillion-Dollar Stem Cell and Gene Therapy Agency Headed Towards New Directions

New priorities are "more crucial than ever," losers and winners expected to emerge, plus CIRM's financial fate

The figures in the above CIRM graphic were accurate at the time of publication, but have changed as more accurate estimates become available. To find the most recent figures, search on this site for the most recent articles dealing with CIRM priorities or the most recent CIRM meeting at which they are discussed. CIRM graphic

California’s stem cell and ge…